Oncolytic Viruses and Viral Gene Therapy Vectors: Principles of Safety
- 11 August 2023
- book chapter
- Published by Springer Nature
- p. 429-442
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope GlycoproteinsHuman Gene Therapy, 2012
- Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma CellsMolecular Therapy, 2012
- Oncolytic Virus Therapy for Glioblastoma MultiformeThe Cancer Journal, 2012
- Distribution of Lentiviral Vector Integration Sites in Mice Following Therapeutic Gene Transfer to Treat β-thalassemiaMolecular Therapy, 2011
- MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector TropismMolecular Therapy, 2011
- MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity Without Impairing Its Antitumor EfficacyMolecular Therapy, 2011
- MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene ExpressionMolecular Therapy, 2011
- Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cellsCancer Gene Therapy, 2010
- Harnessing Endogenous miRNAs to Control Virus Tissue Tropism as a Strategy for Developing Attenuated Virus VaccinesCell Host & Microbe, 2008
- Cell Culture Processes for the Production of Viral Vectors for Gene Therapy PurposesCytotechnology, 2006